Genome wide association studies (GWAS) analyses also demonstrated that variants at the LRRK2 locus, such as single nucleotide polymorphisms, are among the most important genetic risk factors for PD (Monfrini and Di Fonzo, 2017). This evidence concerns the gene LRRK2 and Parkinson disease.